No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
12 Health Care Stocks Moving In Friday's Pre-Market Session
B.Riley Financial Maintains Journey Medical(DERM.US) With Buy Rating, Raises Target Price to $9
B. Riley Adjusts Journey Medical Price Target to $9 From $8, Maintains Buy Rating
US Manufacturing Index Rises To 43, Highest Since 2020
US$9.75 - That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After These Results
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Unlock the Full List